Patient Registry of the European Friedreich's Ataxia Consortium for Translational Studies (EFACTS)

Status: Unknown status
Location: See all (12) locations...
Study Type: Observational [Patient Registry]
SUMMARY

This is a multi-centre, multi-national, prospective, observational study of Friedreich's Ataxia (FRDA) with a control group to: obtain natural history data on individuals affected by FRDA relate clinical assessments and results from proteomic analyses expedite identification and recruitment of participants for clinical trials develop and validate sensitive and reliable outcome measures for detecting onset and change over the natural course of FRDA which may also be potential outcome measures for use in future clinical trials and clinical care plan for future research studies

Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: Accepts Healthy Volunteers
View:

• Genetic diagnosis of FRDA

• For control research participants: genetically confirmed absence of FRDA

Locations
Other Locations
Austria
Medical University Innsbruck, Department of Neurology
Recruiting
Innsbruck
Belgium
Université Libre de Bruxelles
Recruiting
Bruxelles
France
Hôpital Pitié Salpêtrière
Recruiting
Paris
Hôptal de Hautepierre, Department of Neurology
Recruiting
Strasbourg
Germany
University Hospital Aachen, Dept. of Neurology
Recruiting
Aachen
University Hospital Bonn, Dept. of Neurology
Recruiting
Bonn
Philipps University Marburg, Dept. of Neurology
Recruiting
Marburg
University of Munich, Dept. of Neurology
Recruiting
Munich
University of Tübingen, Dept. of Neurodegenerative Diseases, Hertie-Institute for Clinical Brain Research
Recruiting
Tübingen
Italy
Fondazione IRCCS Istituto Neurologico Carlo Besta
Recruiting
Milan
Spain
Hospital Universitario La Paz, Servicio de Neurologia
Recruiting
Madrid
United Kingdom
University College of London, Institute of Neurology
Recruiting
London
Contact Information
Primary
Jörg B. Schulz, MD
jschulz@ukaachen.de
0049-241-80-89600
Backup
Kathrin Reetz, MD
kreetz@ukaachen.de
0049-241-80-89600
Time Frame
Start Date: May 2010
Completion Date: December 2021
Participants
Target number of participants: 900
Treatments
Control research participants
diagnosis of FRDA genetically excluded
FRDA patients
with genetically confirmed diagnosis of FRDA
Sponsors
Leads: European Friedreich's Ataxia Consortium for Translational Studies

This content was sourced from clinicaltrials.gov

Similar Clinical Trials